当前位置:首页 - 行情中心 - 尚荣医疗(002551) - 财务分析 - 现金流量表

尚荣医疗

(002551)

  

流通市值:27.75亿  总市值:38.39亿
流通股本:6.11亿   总股本:8.45亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金650,496,729.51450,935,122.491,297,944,556.7933,930,356.26
  收到的税费返还23,785,302.2113,025,068.7845,082,219.8136,159,286
  收到其他与经营活动有关的现金14,384,743.66,663,740.2253,301,990.3120,971,410.08
  经营活动现金流入小计688,666,775.32470,623,931.491,396,328,766.82991,061,052.34
  购买商品、接受劳务支付的现金440,203,123.57254,120,563.78867,342,947.97494,263,080.56
  支付给职工以及为职工支付的现金130,666,389.2571,991,131.12276,504,078.7186,081,869.37
  支付的各项税费30,855,085.1911,292,499.0538,080,46234,525,216.64
  支付其他与经营活动有关的现金84,962,685.9235,508,030.5993,454,490.6880,070,877.69
  经营活动现金流出小计686,687,283.93372,912,224.541,275,381,979.35794,941,044.26
  经营活动产生的现金流量净额1,979,491.3997,711,706.95120,946,787.47196,120,008.08
二、投资活动产生的现金流量:
  收回投资收到的现金1,174,625,902.11605,279,874.171,362,561,532.31936,922,880.81
  取得投资收益收到的现金6,192,571.432,968,563.543,736,544.14,566,061.62
  处置固定资产、无形资产和其他长期资产收回的现金净额4,001,737.483,106.52,255,129.51118,331.11
  收到的其他与投资活动有关的现金--113,146.38-
  投资活动现金流入小计1,184,820,211.02608,251,544.211,368,666,352.3941,607,273.54
  购建固定资产、无形资产和其他长期资产支付的现金10,952,448.29,990,070.8382,147,569.6526,036,165.53
  投资支付的现金992,000,000517,000,0001,373,500,0001,093,167,764.87
  投资活动现金流出小计1,002,952,448.2526,990,070.831,455,647,569.651,119,203,930.4
  投资活动产生的现金流量净额181,867,762.8281,261,473.38-86,981,217.35-177,596,656.86
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金1,700,0001,650,00036,273,128.1337,038,959.28
  筹资活动现金流入小计1,700,0001,650,00036,273,128.1337,038,959.28
  偿还债务支付的现金267,215,880.09206,465,880.0921,060,00080,720,000
  分配股利、利润或偿付利息支付的现金2,247,501.66968,478.811,033,633.537,865,636.46
  支付其他与筹资活动有关的现金60,250,00060,250,0008,544,331.133,761,523.95
  筹资活动现金流出小计329,713,381.75267,684,358.8940,637,964.6692,347,160.41
  筹资活动产生的现金流量净额-328,013,381.75-266,034,358.89-4,364,836.53-55,308,201.13
四、汇率变动对现金及现金等价物的影响2,553,446.916,574,034.3917,140,717.372,612,218.39
五、现金及现金等价物净增加额-141,612,680.63-80,487,144.1746,741,450.96-34,172,631.52
  加:期初现金及现金等价物余额453,987,150.22453,987,150.22407,245,699.26407,245,699.26
  期末现金及现金等价物余额312,374,469.59373,500,006.05453,987,150.22373,073,067.74
补充资料:
  净利润-4,520,153.56-25,912,519.2-
  资产减值准备-10,253.94-9,154,823.65-
  固定资产和投资性房地产折旧43,400,505.39-87,871,937.63-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧43,400,505.39-87,871,937.63-
  无形资产摊销7,363,866.18-14,519,146.79-
  长期待摊费用摊销788,638.29-2,502,099.42-
  处置固定资产、无形资产和其他长期资产的损失3,104.67--124,830.39-
  固定资产报废损失--1,607,173.67-
  公允价值变动损失3,638,102.83--1,322,766.63-
  财务费用5,102,165.01--8,834,281.72-
  投资损失-7,087,511.07--2,701,178.47-
  递延所得税-1,094,371.68--1,562,490.84-
  其中:递延所得税资产减少-678,780.71--2,348,698.01-
    递延所得税负债增加-415,590.97-786,207.17-
  存货的减少24,852,438.73-105,767,900.84-
  经营性应收项目的减少69,158,862.33--144,575,483.92-
  经营性应付项目的增加-122,303,311.68-2,896,228.26-
  现金的期末余额312,374,469.59-453,987,150.22-
  减:现金的期初余额453,987,150.22-407,245,699.26-
  现金及现金等价物的净增加额-141,612,680.63-46,741,450.96-
公告日期2025-08-262025-04-292025-04-292024-10-29
审计意见(境内)标准无保留意见
TOP↑